Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

1.69
Delayed Data
As of Feb 16
 -0.03 / -1.74%
Today’s Change
1.20
Today|||52-Week Range
6.24
+2.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization25.0K45.0K160.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income-25.0K-45.0K-160.0K-41.0K
 
 
 
 
 
General Expenses14.6M10.7M8.5M7.9M
 
 
 
 
 
Research And Development10.8M7.8M7.0M6.1M
 
 
 
 
 
Total Operating Expenses14.6M10.7M8.7M7.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.6M-10.7M-8.7M-7.9M
 
 
 
 
 
Extraordinary Credit1.6M0.009.0M1.7M
 
 
 
 
Extraordinary Charge0.00-600.0K0.000.00
 
 
Other Expenses19.0K97.0K-28.0K-43.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-13.0M-11.2M313.0K-6.3M
 
 
 
 
 
Preferred Dividend-2.1M-2.5M0.000.00
 
 
 
Net Income-13.0M-11.2M313.0K-6.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.3M6.8M10.1M10.9M
 
 
 
 
 
Shares To Calculate EPS Diluted5.3M6.8M10.1M10.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.88-$16.24$0.03-$0.58
 
 
 
 
 
EPS Diluted-$2.88-$2.03$0.03-$0.58